title: Aortic and mitral valve thickening with concentric left ventricular hypertrophy in an elite bodybuilder: a biochemical and/or physiological adaptation?
authors.forename: Qualls E J
authors.initials: QE
authors.lastname: Stevens
authors.forename: Rob  D
authors.initials: R
authors.lastname: Dickerman
authors.forename: Walter J
authors.initials: WJ
authors.lastname: McConathy
authors.forename: Frederick
authors.initials: F
authors.lastname: Schaller
mesh_terms: D000222:Adaptation, Physiological / Q000187:drug effects / Q000502:physiology; D000328:Adult; D001021:Aortic Valve / Q000000981:diagnostic imaging / Q000187:drug effects / Q000503:physiopathology*; D015415:Biomarkers / Q000097:blood; D015992:Body Mass Index; D004305:Dose-Response Relationship, Drug; D004452:Echocardiography; D006349:Heart Valve Diseases / Q000139:chemically induced / Q000175:diagnosis / Q000503:physiopathology*; D019382:Human Growth Hormone / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000139:chemically induced / Q000175:diagnosis / Q000503:physiopathology*; D008297:Male; D008943:Mitral Valve / Q000000981:diagnostic imaging / Q000187:drug effects / Q000503:physiopathology*; D012850:Sinus of Valsalva / Q000000981:diagnostic imaging / Q000187:drug effects / Q000503:physiopathology; D013008:Somatotypes / Q000502:physiology*; D013177:Sports
chemical_list: D015415:Biomarkers; D019382:Human Growth Hormone